NDC 70000-0502-01 - Leader Dry Eye Relief Eye Drops
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70000-0502
- Requested NDC
- 70000-0502-01
- Package NDCs from labels
- 70000-0502-1, 70000-0502-2, 70000-0502-01
- Manufacturer
- CARDINAL HEALTH 110, LLC. DBA LEADER | KC Pharmaceuticals, Inc.
- Effective date
- 2026-08-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Leader Dry Eye Relief Eye Drops (PLD) | CARDINAL HEALTH 110, LLC. DBA LEADER | KC Pharmaceuticals, Inc. | 2026-08-17 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70000-0502-1 | Leader Dry Eye Relief Eye Drops | 1 in 1 CARTON | SOLUTION/ DROPS | 1 | 7 | |
| 70000-0502-1 | Leader Dry Eye Relief Eye Drops | 15 mL in 1 BOTTLE, PLASTIC | SOLUTION/ DROPS | 15 | 7 | |
| 70000-0502-2 | Leader Dry Eye Relief Eye Drops | 2 in 1 CARTON | SOLUTION/ DROPS | 2 | 7 | |
| 70000-0502-2 | Leader Dry Eye Relief Eye Drops | 15 mL in 1 BOTTLE, PLASTIC | SOLUTION/ DROPS | 15 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70000-0502 | LEADER DRY EYE RELIEF EYE DROPS (GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400) SOLUTION/ DROPS [CARDINAL HEALTH] | 5 | Current NDC, Legacy NDC, 4 package rows | 20240104_2ded4bda-b3c3-4521-8701-5c8446fd148b.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70000-0502-1 | ML - Milliliter | 70000-0502 | 1f203b31-da5d-4e94-9c33-96546f6e91ec | 1 | 2020-02-13 |
| 70000-0502-2 | ML - Milliliter | 70000-0502 | cf12542e-c79c-433c-bb69-279435fa1c48 | 1 | 2020-04-20 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rohto Dual Light Relief | HYPROMELLOSE, POVIDONE | The Mentholatum Company | 1b597f83-d7f1-cf93-e063-6394a90a99f7 | 2026-06-19 | Warnings | M018 3NXW29V3WO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | HF Acquisition Co LLC, DBA HealthFirst | d8516f38-6f92-32d1-e053-2995a90a96bf | 2026-06-19 | Warnings, Adverse reactions | 8MDF5V39QO |
| Pain Relieving cleansing spary | BENZALKONIUM CHLORIDE AND LIDOCAINE HCI | Trifecta Pharmaceuticals USA, LLC. | 48edbb8d-0c35-91d8-e063-6394a90a71b8 | 2026-06-19 | Warnings | F5UM2KM3W7 |
| Dove | ANTIBACTERIAL CARE BEAUTY BAR | Conopco d/b/a Unilever | 547472cf-4902-584e-e063-6294a90a28ac | 2026-06-17 | Warnings | F5UM2KM3W7 |
| Humalog | INSULIN LISPRO | Eli Lilly and Company | c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f | 2026-06-16 | Warnings, Adverse reactions | 059QF0KO0R |
| Glycerin | GLYCERIN SUPPOSITORY | Everpharm LLC | 546347e5-841e-15ca-e063-6294a90a0c8b | 2026-06-16 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN SUPPOSITORY | Everpharm LLC | 5463f869-2b92-4551-e063-6394a90ad6f9 | 2026-06-16 | Warnings | PDC6A3C0OX |
| MINICA-S | GLYCERIN | Sato Pharmaceutical Co., Ltd. | 687902eb-e702-4e87-a0ce-9add05e3cbc1 | 2026-06-16 | Warnings | PDC6A3C0OX |
| 0.9% Sodium Chloride Saline Solution | SODIUM CHLORIDE | Yunqi Cosmetics (Shenzhen) Co., Ltd | 546af257-dbd1-11fc-e063-6394a90a8e0a | 2026-06-16 | Warnings | 451W47IQ8X |
| Sodium Bicarbonate | SODIUM BICARBONATE, INJECTION | Civica, Inc. | 3737e5e5-2296-4a3d-b8f1-dfea1eff1927 | 2026-06-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| E-Z-GAS II | ANTACID/ANTIFLATULENT | E-Z-EM, INC. | 4e12e1cb-b033-076d-e054-00144ff8d46c | 2026-06-15 | Warnings | 8MDF5V39QO |
| BM BM68 DROPS | ARGENTUM NIT, BARYTA CARB., DULCAMARA, GELSEMIUM, KALI BROM, NAT MUR, CAUSTICUM | BM Private Limited | 53f9c99a-0f20-0358-e063-6394a90af4e0 | 2026-06-15 | Warnings | 451W47IQ8X |
| BM BM68 | ARGENTUM NIT, BARYTA CARB, DULCAMARA, GELSEMIUM, KALI BROM, NAT MUR, CAUSTICUM | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5448c76a-2ecb-9402-e063-6294a90a6ad7 | 2026-06-15 | Warnings | 451W47IQ8X |
| BM BIO28 ALCOHOL | CALC SULPH, CALC FLUOR, CALC PHOS, FERR PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT PHOS, NAT SULPH, NAT MUR, SILICEA | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 544b66c4-49df-556f-e063-6394a90af3ed | 2026-06-15 | Warnings | 451W47IQ8X 660YQ98I10 |
| WALGREEN GLYCERIN ADULT | GLYCERIN SUPPOSITORY | Walgreens | 20c44346-0b29-7364-e063-6294a90a648f | 2026-06-15 | Warnings | PDC6A3C0OX |
| WALGREENS GLYCERIN | GLYCERIN SUSPENSION | Walgreens | 20c44346-0b2b-7364-e063-6294a90a648f | 2026-06-15 | Warnings | PDC6A3C0OX |
| Antiseptic | BENZALKONIUM CHLORIDE, BENZOCAINE | Wildman Business Group | 1fd15b91-6b81-d0bd-e063-6294a90a4d27 | 2026-06-15 | Warnings | F5UM2KM3W7 |
| Lubricant Eye | CARBOXYMETHYLCELLULOSE SODIUM 0.5% | CARDINAL HEALTH 110, LLC. DBA LEADER | 51a2d74f-5ff3-9921-e063-6294a90a345a | 2026-06-15 | Warnings | M018 |
| Lubricant Eye | CARBOXYMETHYLCELLULOSE SODIUM | Rugby Laboratories | 51cadca6-a31b-c1b5-e063-6394a90a34d3 | 2026-06-15 | Warnings | M018 |
| Male Support | AGNUS CASTUS, AURUM METALLICUM, BENZOICUM ACIDUM, BRYONIA (ALBA), BUFO RANA, CALADIUM SEGUINUM, CHIMAPHILA UMBELLATA, CLEMATIS ERECTA, CONIUM MACULATUM, CORTISONE ACETICUM, HYPOTHALAMUS SUIS, KALI ARSENICOSUM, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, PROSTATE (SUIS), RHODODENDRON CHRYSANTHUM, SABAL SERRULATA, SELENIUM METALLICUM, SEPIA, TESTOSTERONE, THUJA OCCIDENTALIS | Deseret Biologicals, Inc. | 29cefc89-3bb6-484e-84ab-116b5827a4c3 | 2026-06-15 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.